Vaginal Vault Prolapse Clinical Trial
Official title:
Prospective Randomized Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of a Vaginal and Laparoscopic Method With Validation of Translated Questionnaire for Symptoms and Quality of Life by Vaginal Prolapse.
The study is carried out at the Sahlgrenska University Hospital and the patient population consists of women referred with symptomatic and bothersome post-hysterectomy vaginal vault prolapse at least 1 cm above or beyond the hymeneal remnants. The interventions are either vaginal sacrospinousfixation or laparoscopic sacrocolpopexy following randomization to one of the types of surgery. The primary outcome is anatomical failure based on clinical assessment. Failure is defined clinically, according to the Pelvic Organ Prolapse Quantification system, as Ba, C or Bp at the hymen or below on maximum Valsalva maneuver one and two years after the surgery. Secondary outcomes are evaluation of continence, sexual function and prolapse symptoms based on validated questionnaires 1, 2, 5 and 10 years after the surgery.
The lifetime risk for pelvic floor surgery for prolapse is likely to be between 10% and 15%,
and a large number of patients who previously underwent hysterectomy develop vaginal vault
prolapse. There is some evidence that about 2% of all women after hysterectomy would require
a surgery for vault prolapse. There are many different techniques used for correction of
vault prolapse but the evidence for them is lacking and the use is guided mainly by
tradition at the singe institution.
There is some evidence indicating that laparoscopic surgery can be superior to the vaginal
approach. Symptoms of prolapse are significantly associated with avulsion injury in patients
after hysterectomy.
Our aim is to compare, with a 1- and 2-years follow-up examination in patients with
post-hysterectomy prolapse, the efficacy of two standard surgical procedures for vaginal
vault prolapse: sacrospinous vaginal colpopexy (the Richter procedure) with native tissue
vaginal repair (sacrospinous fixation, SSF) and laparoscopic colposacropexy with mesh.
This is a single-center, randomized controlled trial of two standard surgical procedures for
vaginal vault prolapse routinely used at our institution.Both procedures are designed to
treat vault prolapse, one with mesh implantation through laparoscopy and the other with
vaginal repairs and apical fixation to the sacrospinous ligament, usually on the right.
All patients referred to our gynecological unit (Ob/Gyn Department of Sahlgrenska University
Hospital in Gothenburg) because of symptomatic vault prolapse and fulfilling the inclusions
criteria are asked to participate in the study. Eligible for inclusion are:
post-hysterectomy patients with at least two-compartment prolapse (with affected
apical/vault compartment, stage II or higher on the Pelvic Organ Prolapse Quantification
system (POP-Q)), suffering from symptoms of prolapse, requesting pelvic floor reconstructive
surgery, and diagnosed with a vault prolapse. Excluded are: patients with prolapse and
uterus in place, those not requesting pelvic floor surgery, patients who do not understand
Swedish or are not capable to fulfill follow up procedure.
Patients undergo identical pre- and postoperative assessment procedures, including POP-Q
examination on maximum Valsalva maneuver, which are archived on Case Report Form, and
validated questionnaires PFDI-20, PFIQ-7 and PISQ-12. The study was approved by the regional
ethics committee and all subjects obtain written informed consent to participate. To
minimize the bias we decided that all the follow up examinations are going to be performed
by the same gynecologist who do not perform the surgery.
All patients can end participation in the study at any moment.
The randomization process is carried out by computer, using patient social security number,
at the time of enrollment (usually 2-3 months before the surgery). Patients are informed
about their allocation after the randomization. Both procedures are performed by an
experienced surgeon, with the patient under general anesthesia for the laparoscopic
procedure and regional anesthesia for the sacrospinous fixation.
Patients are followed up at 3 months,1 year and 2 years postoperatively. These postoperative
clinical examinations are performed by a single examiner, who had not been involved in the
surgical procedures. The vaginal descent was assessed at maximum Valsalva maneuver.
In case of recurrence of prolapse and distressing symptoms which a patient desired to be
resolved, a reoperation of prolapse is planned according to the clinical praxis at our
department.
The primary outcome measure was anatomical failure based on clinical assessment. Failure was
defined clinically as Ba, C or Bp at the hymen or below, on maximum Valsalva maneuver.
As secondary outcome measures we used a continence status, sexual function and prolapse
symptoms based on validated questionnaires: Pelvic Floor Impact Questionnaire (PFIQ - 7),
Pelvic Floor Distress Inventory Questionnaire - Short Form 20 (PFDI-20), Pelvic Organ
Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and quality of life based on
Short Form (36) Health Survey.
The power calculation was based on the primary outcome measure and available data which led
us to expect a failure rate of 25% in the sacrospinous fixation group and 10% failure in
laparoscopy group. To detect an expected difference of 15% between the groups, with 80%
power of the test 70 patients are required in each group.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03681223 -
Restorelle® Y Mesh vs. Vertessa® Lite Y Mesh for Laparoscopic and Robotic-assisted Laparoscopic Sacrocolpopexy
|
N/A | |
Active, not recruiting |
NCT03714607 -
Laser Therapy in Managing Vaginal Prolapse
|
N/A | |
Recruiting |
NCT04172896 -
Intraperitoneal and Extraperitoneal Uterosacral Ligament Suspensions for Post-Hysterectomy Vaginal Vault Prolapse
|
N/A | |
Completed |
NCT01840176 -
Prophylactic Modified McCall Culdoplasty During Total Laparoscopic Hysterectomy
|
N/A | |
Active, not recruiting |
NCT01097200 -
Sacrocolpopexy Versus Vaginal Mesh Procedure for Pelvic Prolapse
|
N/A | |
Completed |
NCT00223106 -
Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse
|
N/A | |
Recruiting |
NCT05628831 -
Traditional Vaginal Surgery VS Autologous Tissue in Pelvic Floor Repair
|
N/A | |
Completed |
NCT02680145 -
Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use
|
N/A | |
Completed |
NCT01394237 -
Laparoscopic Sacrocolpopexy: Long Term Follow-up
|
N/A | |
Recruiting |
NCT00928239 -
Laparoscopic Sacropexy: Comparison of Mesh Attachment
|
N/A | |
Recruiting |
NCT05688059 -
Absorbable Suture vs Permanent Suture in Sacrospinous Ligament Suspension
|
N/A | |
Completed |
NCT01244165 -
Study of Cytrix Use in Pelvic Floor Prolapse Treatment
|
Phase 4 | |
Completed |
NCT02431897 -
Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen
|
Phase 4 | |
Completed |
NCT04038099 -
Lessons on Urethral Lidocaine in Urodynamics
|
Phase 4 | |
Recruiting |
NCT05960292 -
Laparoscopic Versus Vaginal Approach Closure Complications
|
N/A | |
Recruiting |
NCT00886223 -
Laparoscopic Sacropexy With Robot-Assisted Surgical System
|
N/A |